T2 Biosystems Announces Commercial Expansion Through Middle
Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated May 6, 2024 Relating to Preliminary Prospectus dated May 6, 2024 Registration No....
Stay updated with breaking news from John Sperzel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Filed Pursuant to Rule 433 Issuer Free Writing Prospectus dated May 6, 2024 Relating to Preliminary Prospectus dated May 6, 2024 Registration No....
28.03.2024 - LEXINGTON, Mass., March 28, 2024 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that its multi-year capital equipment supplier ... Seite 1
T2 Biosystems, Inc. (NASDAQ:TTOO) Q4 2023 Earnings Call Transcript February 15, 2024 T2 Biosystems, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, everyone. And welcome to the T2 Biosystems Preliminary Fourth Quarter and Full Year 2023 Results […]
15.02.2024 - LEXINGTON, Mass., Feb. 15, 2024 (GLOBE NEWSWIRE) - T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistant genes, today announced the execution of territory exclusive distribution ...
LEXINGTON, Mass., Feb. 07, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO) a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the U.S.